Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates
Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates In the realm of pharmaceutical clinical trials, hybrid and decentralized clinical trials (DCTs) are transforming the way studies are conducted. However, high deviation rates can introduce significant challenges. This article presents a comprehensive,…
Read More “Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates” »